[ad_1]
Take heed to this text |
Levita Magnetics introduced the world’s first industrial use for its MARS magnetic-assisted robotic surgical procedure platform.
Dr. Matthew Kroh and Dr. Andrew Robust carried out the primary minimally invasive procedures with the system on the Cleveland Clinic. The procedures happened final month, simply over a month after the FDA cleared the MARS system.
In a information launch, Kroh stated MARS might doubtlessly “play a pivotal position in reshaping the panorama of stomach procedures.”
“MARS represents a noteworthy development and is a part of the pathway to reinforce minimally invasive surgical procedure for healthcare establishments, surgeons, and most significantly, for sufferers,” stated Kroh, the vice chair of innovation and expertise on the Cleveland Clinic. “It’s additionally remarkably simple to make use of.”
Extra in regards to the Levita Magnetics MARS system
Mountain View, California-based Levita designed the MARS platform for the high-volume stomach surgical procedure market. It combines magnets and machines to scale back the variety of incisions. The system permits full management throughout laparoscopic procedures, the corporate says.
Leveraging Levita’s proprietary Dynamic Magnetic Positioning expertise, the system can help in laparoscopic bariatric surgical procedures, cholecystectomy (gallbladder), prostate and colorectal procedures.
MARS is available in a compact footprint designed to suit into present working rooms. It builds on the success of the corporate’s first industrial product, the Levita Magnetic Surgical System. Levita designed MARS to ship the identical affected person advantages whereas empowering surgeons with elevated management of surgical devices.
The corporate stated the system supplies quicker restoration, much less ache and fewer scars. MARS’ surgeon-controlled arms present full management over the laparoscopic view and magnetic retractor. This reduces the necessity for a further assistant.
“We’re thrilled to have initiated profitable industrial procedures using the MARS system so quickly after receiving FDA clearance. We’re at the vanguard of a major shift within the method to high-volume minimally-invasive stomach surgical procedure in america and on the earth,” said Dr. Alberto Rodriguez-Navarro, founder and CEO of Levita Magnetics. “We goal to indicate that this revolutionary expertise can empower surgeons with elevated management and higher visualization whereas lowering the variety of incisions, delivering vital affected person advantages. The MARS system can play a significant position within the transition of excessive quantity stomach procedures to an ambulatory or same-day discharge setting.”
[ad_2]
Source link